DAFNA Capital Management as of Sept. 30, 2017
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 73 positions in its portfolio as reported in the September 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Loxo Oncology | 15.0 | $24M | 262k | 92.12 | |
AtriCure (ATRC) | 5.3 | $8.6M | 384k | 22.37 | |
Beigene (BGNE) | 4.6 | $7.4M | 72k | 103.45 | |
Immunomedics | 4.0 | $6.4M | 461k | 13.98 | |
BioCryst Pharmaceuticals (BCRX) | 3.9 | $6.3M | 1.2M | 5.24 | |
NxStage Medical | 3.7 | $6.0M | 216k | 27.60 | |
Aerie Pharmaceuticals | 3.5 | $5.7M | 117k | 48.60 | |
Blueprint Medicines (BPMC) | 3.3 | $5.3M | 76k | 69.67 | |
Alder Biopharmaceuticals | 2.6 | $4.2M | 346k | 12.25 | |
Radius Health Inc note 3.000% 9/0 | 2.5 | $4.0M | 4.0M | 1.00 | |
Cymabay Therapeutics | 2.2 | $3.5M | 435k | 8.06 | |
Neurocrine Biosciences (NBIX) | 2.1 | $3.3M | 55k | 61.28 | |
Achillion Pharmaceuticals | 2.0 | $3.2M | 718k | 4.49 | |
Galapagos Nv- (GLPG) | 2.0 | $3.2M | 32k | 101.74 | |
Insulet Corporation (PODD) | 2.0 | $3.2M | 58k | 55.08 | |
iShares NASDAQ Biotechnology Index (IBB) | 1.8 | $2.9M | 8.7k | 333.56 | |
Macrogenics (MGNX) | 1.8 | $2.8M | 154k | 18.48 | |
Dex (DXCM) | 1.8 | $2.8M | 58k | 48.92 | |
Insulet Corp note 2.000% 6/1 | 1.8 | $2.8M | 2.3M | 1.25 | |
Akebia Therapeutics (AKBA) | 1.7 | $2.7M | 136k | 19.67 | |
Ascendis Pharma A S (ASND) | 1.6 | $2.6M | 72k | 36.25 | |
Voyager Therapeutics (VYGR) | 1.5 | $2.4M | 117k | 20.59 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.3 | $2.1M | 2.5M | 0.85 | |
Radius Health | 1.3 | $2.1M | 53k | 38.55 | |
Dermira | 1.3 | $2.0M | 76k | 27.01 | |
Zogenix | 1.1 | $1.8M | 53k | 35.05 | |
Ardelyx (ARDX) | 1.1 | $1.8M | 325k | 5.60 | |
Aeglea Biotherapeutics | 1.1 | $1.7M | 350k | 4.93 | |
Uniqure Nv (QURE) | 1.1 | $1.7M | 175k | 9.60 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 1.1 | $1.7M | 209k | 8.10 | |
Applied Genetic Technol Corp C | 1.0 | $1.7M | 421k | 3.95 | |
Biotelemetry | 1.0 | $1.7M | 50k | 33.00 | |
Dermira Inc note 3.000% 5/1 | 1.0 | $1.6M | 1.5M | 1.08 | |
Sunesis Pharmaceuticals Inc Ne | 1.0 | $1.6M | 831k | 1.94 | |
Kura Oncology (KURA) | 1.0 | $1.6M | 106k | 14.95 | |
Neuroderm Ltd F | 0.9 | $1.5M | 38k | 38.91 | |
Foamix Pharmaceuticals | 0.9 | $1.4M | 259k | 5.55 | |
Minerva Neurosciences | 0.8 | $1.3M | 171k | 7.60 | |
Cara Therapeutics (CARA) | 0.8 | $1.3M | 94k | 13.69 | |
Johnson & Johnson (JNJ) | 0.8 | $1.2M | 9.4k | 130.00 | |
Scynexis | 0.8 | $1.2M | 507k | 2.41 | |
Rigel Pharmaceuticals (RIGL) | 0.7 | $1.1M | 444k | 2.54 | |
Stereotaxis (STXS) | 0.7 | $1.1M | 1.4M | 0.82 | |
Aquinox Pharmaceuticals | 0.7 | $1.1M | 80k | 14.19 | |
Xenon Pharmaceuticals (XENE) | 0.7 | $1.1M | 378k | 2.95 | |
Advaxis | 0.6 | $1.0M | 247k | 4.18 | |
Clementia | 0.6 | $1.0M | 60k | 16.88 | |
Exactech | 0.6 | $907k | 28k | 32.94 | |
Argenx Se (ARGX) | 0.6 | $904k | 40k | 22.60 | |
Cogentix Medical | 0.5 | $828k | 324k | 2.56 | |
Obseva Sa | 0.4 | $700k | 86k | 8.14 | |
Ironwood Pharmaceuticals Inc dbcv 2.250% 6/1 | 0.4 | $682k | 573k | 1.19 | |
Bluebird Bio (BLUE) | 0.4 | $618k | 4.5k | 137.33 | |
Luminex Corporation | 0.3 | $508k | 25k | 20.32 | |
Cascadian Therapeutics | 0.3 | $480k | 117k | 4.09 | |
ArQule | 0.3 | $475k | 428k | 1.11 | |
Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.3 | $462k | 600k | 0.77 | |
Masimo Corporation (MASI) | 0.3 | $433k | 5.0k | 86.60 | |
Kadmon Hldgs | 0.3 | $419k | 125k | 3.35 | |
Deciphera Pharmaceuticals (DCPH) | 0.2 | $380k | 20k | 19.00 | |
Natus Medical | 0.2 | $296k | 7.9k | 37.47 | |
Neos Therapeutics | 0.2 | $252k | 28k | 9.16 | |
Bellicum Pharma | 0.1 | $231k | 20k | 11.55 | |
Dexcom Inc dbcv 0.750% 5/1 | 0.1 | $223k | 250k | 0.89 | |
Edge Therapeutics | 0.1 | $208k | 19k | 10.72 | |
Actinium Pharmaceuticals | 0.1 | $193k | 333k | 0.58 | |
Ophthotech | 0.1 | $141k | 50k | 2.82 | |
Adamis Pharmaceuticals Corp Com Stk | 0.1 | $127k | 24k | 5.20 | |
Intec Pharma Ltd Jerusalem | 0.1 | $126k | 14k | 8.94 | |
Cytomx Therapeutics (CTMX) | 0.1 | $107k | 5.9k | 18.14 | |
Spring Bk Pharmaceuticals In | 0.1 | $110k | 6.5k | 16.90 | |
Sierra Oncology | 0.0 | $68k | 44k | 1.55 | |
Galena Biopharma | 0.0 | $16k | 46k | 0.35 |